<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Teriparatide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Teriparatide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Teriparatide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Teriparatide</b> is a form of parathyroid hormone consisting of the first (N-terminus) 34 amino acids, which is the bioactive portion of the hormone. It is an effective anabolic (promoting bone formation) agent<span class="mw-ref" id="cite_ref-Riek_2-0"><a href="#cite_note-Riek-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> used in the treatment of some forms of osteoporosis.<span class="mw-ref" id="cite_ref-pmid18003959_3-0"><a href="#cite_note-pmid18003959-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is also occasionally used off-label to speed fracture healing. Teriparatide is identical to a portion of human parathyroid hormone (PTH) and intermittent use activates osteoblasts more than osteoclasts, which leads to an overall increase in bone.</p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Teriparatide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Teriparatide_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Teriparatide_structure.svg.png" data-file-width="2044" data-file-height="1661" data-file-type="drawing" height="203" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Forteo/Forsteo, Teribone<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/teriparatide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/teriparatide.html'" tppabs="https://www.drugs.com/monograph/teriparatide.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Teriparatide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Teriparatide'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Teriparatide" class="external text external">by INN</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>C</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Subcutaneous</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>H05AA02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=H05AA02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=H05AA02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=H05AA02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>95%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Hepatic (nonspecific proteolysis)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>Subcutaneous: 1 hour</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Renal (metabolites)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=52232-67-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=52232-67-4'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=52232-67-4" class="external text external">52232-67-4</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/16132393  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/16132393'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/16132393" class="external text external">16132393</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB06285  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB06285'" tppabs="https://www.drugbank.ca/drugs/DB06285" class="external text external">DB06285</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.17289052.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.17289052.html'" tppabs="http://www.chemspider.com/Chemical-Structure.17289052.html" class="external text external">17289052</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=10T9CSU89I  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=10T9CSU89I'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=10T9CSU89I" class="external text external">10T9CSU89I</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D06078  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D06078'" tppabs="https://www.kegg.jp/entry/D06078" class="external text external">D06078</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.168.733  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.168.733'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.168.733" class="external text external">100.168.733</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>181</sub><span>H</span><sub>291</sub><span>N</span><sub>55</sub><span>O</span><sub>51</sub><span>S</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">4<span style="margin-left:.25em;">117</span>.77</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BH%5D%2FN%3DC%28%5CN%29%2FNCCC%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28C%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCC%28%3DO%29O%29C%28%3DO%29N%5BC%40%40H%5D%28Cc1c%5BnH%5Dc2c1cccc2%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCCN%2FC%28%3DN%2F%5BH%5D%29%2FN%29C%28%3DO%29N%5BC%40%40H%5D%28CCCCN%29C%28%3DO%29N%5BC%40%40H%5D%28CCCCN%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCC%28%3DO%29N%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28%3DO%29O%29C%28%3DO%29N%5BC%40%40H%5D%28C%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28Cc3cnc%5BnH%5D3%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28%3DO%29N%29C%28%3DO%29N%5BC%40%40H%5D%28Cc4ccccc4%29C%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CCSC%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28Cc5cnc%5BnH%5D5%29NC%28%3DO%29%5BC%40H%5D%28CCCCN%29NC%28%3DO%29CNC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28Cc6cnc%5BnH%5D6%29NC%28%3DO%29%5BC%40H%5D%28CCSC%29NC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28%5BC%40%40H%5D%28C%29CC%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28C%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CO%29N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BH%5D%2FN%3DC%28%5CN%29%2FNCCC%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28C%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCC%28%3DO%29O%29C%28%3DO%29N%5BC%40%40H%5D%28Cc1c%5BnH%5Dc2c1cccc2%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCCN%2FC%28%3DN%2F%5BH%5D%29%2FN%29C%28%3DO%29N%5BC%40%40H%5D%28CCCCN%29C%28%3DO%29N%5BC%40%40H%5D%28CCCCN%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCC%28%3DO%29N%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28%3DO%29O%29C%28%3DO%29N%5BC%40%40H%5D%28C%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28Cc3cnc%5BnH%5D3%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28%3DO%29N%29C%28%3DO%29N%5BC%40%40H%5D%28Cc4ccccc4%29C%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CCSC%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28Cc5cnc%5BnH%5D5%29NC%28%3DO%29%5BC%40H%5D%28CCCCN%29NC%28%3DO%29CNC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28Cc6cnc%5BnH%5D6%29NC%28%3DO%29%5BC%40H%5D%28CCSC%29NC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28%5BC%40%40H%5D%28C%29CC%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28C%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CO%29N'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BH%5D%2FN%3DC%28%5CN%29%2FNCCC%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28C%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCC%28%3DO%29O%29C%28%3DO%29N%5BC%40%40H%5D%28Cc1c%5BnH%5Dc2c1cccc2%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCCN%2FC%28%3DN%2F%5BH%5D%29%2FN%29C%28%3DO%29N%5BC%40%40H%5D%28CCCCN%29C%28%3DO%29N%5BC%40%40H%5D%28CCCCN%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28CCC%28%3DO%29N%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28%3DO%29O%29C%28%3DO%29N%5BC%40%40H%5D%28C%28C%29C%29C%28%3DO%29N%5BC%40%40H%5D%28Cc3cnc%5BnH%5D3%29C%28%3DO%29N%5BC%40%40H%5D%28CC%28%3DO%29N%29C%28%3DO%29N%5BC%40%40H%5D%28Cc4ccccc4%29C%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CCSC%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28Cc5cnc%5BnH%5D5%29NC%28%3DO%29%5BC%40H%5D%28CCCCN%29NC%28%3DO%29CNC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28Cc6cnc%5BnH%5D6%29NC%28%3DO%29%5BC%40H%5D%28CCSC%29NC%28%3DO%29%5BC%40H%5D%28CC%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29N%29NC%28%3DO%29%5BC%40H%5D%28%5BC%40%40H%5D%28C%29CC%29NC%28%3DO%29%5BC%40H%5D%28CCC%28%3DO%29O%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28C%28C%29C%29NC%28%3DO%29%5BC%40H%5D%28CO%29N" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">[H]/N=C(\N)/NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN/C(=N/[H])/N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc4ccccc4)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc5cnc[nH]5)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](Cc6cnc[nH]6)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C181H291N55O51S2/c1-21-96(18)146(236-160(267)114(48-53-141(250)251)212-174(281)132(84-239)232-177(284)143(93(12)13)233-147(254)103(185)82-237)178(285)216-111(45-50-134(187)241)155(262)219-119(65-90(6)7)163(270)213-116(55-62-289-20)158(265)224-124(71-100-79-196-86-203-100)167(274)226-126(73-135(188)242)169(276)217-117(63-88(2)3)148(255)201-81-138(245)205-105(39-27-30-56-182)149(256)223-123(70-99-78-195-85-202-99)166(273)221-121(67-92(10)11)164(271)225-128(75-137(190)244)171(278)231-131(83-238)173(280)214-115(54-61-288-19)157(264)210-112(46-51-139(246)247)153(260)208-109(43-34-60-199-181(193)194)159(266)234-144(94(14)15)175(282)215-113(47-52-140(248)249)156(263)222-122(69-98-77-200-104-38-26-25-37-102(98)104)165(272)220-120(66-91(8)9)161(268)209-108(42-33-59-198-180(191)192)151(258)206-106(40-28-31-57-183)150(257)207-107(41-29-32-58-184)152(259)218-118(64-89(4)5)162(269)211-110(44-49-133(186)240)154(261)228-129(76-142(252)253)172(279)235-145(95(16)17)176(283)229-125(72-101-80-197-87-204-101)168(275)227-127(74-136(189)243)170(277)230-130(179(286)287)68-97-35-23-22-24-36-97/h22-26,35-38,77-80,85-96,103,105-132,143-146,200,237-239H,21,27-34,39-76,81-84,182-185H2,1-20H3,(H2,186,240)(H2,187,241)(H2,188,242)(H2,189,243)(H2,190,244)(H,195,202)(H,196,203)(H,197,204)(H,201,255)(H,205,245)(H,206,258)(H,207,257)(H,208,260)(H,209,268)(H,210,264)(H,211,269)(H,212,281)(H,213,270)(H,214,280)(H,215,282)(H,216,285)(H,217,276)(H,218,259)(H,219,262)(H,220,272)(H,221,273)(H,222,263)(H,223,256)(H,224,265)(H,225,271)(H,226,274)(H,227,275)(H,228,261)(H,229,283)(H,230,277)(H,231,278)(H,232,284)(H,233,254)(H,234,266)(H,235,279)(H,236,267)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,286,287)(H4,191,192,198)(H4,193,194,199)/t96-,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,143-,144-,145-,146-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:OGBMKVWORPGQRR-UMXFMPSGSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=447111676&page2=Teriparatide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=447111676&page2=Teriparatide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=447111676&page2=Teriparatide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>
<p>Recombinant teriparatide is sold by Eli Lilly and Company under the brand name <b>Forteo/Forsteo</b>. On June 11, 2020 Alvogen, Inc, Pfenex Inc.’s commercialization partner, launched Teriparatide Injection in the United States.  Teriparatide Injection is the product developed by Pfenex Inc and was approved by the US FDA On October 4, 2019. Teriparatide Injection is pharmaceutically equivalent to Forteo (that is, has the same active ingredient in the same strength, dosage form and route of administration) and has been shown to have comparable bioavailability. &nbsp;These characteristics allowed the product to be approved under a 505(b)(2) NDA for which Forteo was the reference drug. &nbsp;It may provide a lower-cost teriparatide option for increasing bone density in patients at high risk for fracture,  and is FDA-approved for the same indications as Forteo, which means it can be used for the same patients as Forteo, including new patients and those currently responding to treatment. </p>

<p>Teriparatide was approved for medical use in the European Union in June 2003.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> A synthetic teriparatide from Teva Generics has been authorised for marketing in European territories.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Biosimilar product from Gedeon Richter plc has been authorised in the European Union.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> On October 4, 2019 the US FDA approved a recombinant teriparatide product, PF708,  from Pfenex Inc. PF708 is the first FDA approved proposed therapeutic equivalent candidate to Forteo.</p>

<p>In June 2020, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of the biosimilar products Qutavina and Livogiva.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Teriparatide has been FDA-approved since 2002.<span class="mw-ref" id="cite_ref-Rizzoli_9-0"><a href="#cite_note-Rizzoli-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It is effective in growing bone (e.g., 8% increase in bone density in the spine after one year)<span class="mw-ref" id="cite_ref-Kawai_10-0"><a href="#cite_note-Kawai-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> and reducing the risk of fragility fractures.<span class="mw-ref" id="cite_ref-Rizzoli_9-1"><a href="#cite_note-Rizzoli-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-Murad_11-0"><a href="#cite_note-Murad-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> When studied, teriparatide only showed bone mineral density (BMD) improvement during the first 18 months of use. Teriparatide should only be used for a period of 2 years maximum. After 2 years, another agent such a bisphosphonate or denosumab should be used in cases of osteoporosis. <span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>Teriparatide cuts the risk of hip fracture by more than half but does not reduce the risk of arm or wrist fracture.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p> 


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other">Other</h3></summary>
    
<p>Teriparatide can be used off-label to speed fracture repair and treat fracture nonunions.<span class="mw-ref" id="cite_ref-Jancin_14-0"><a href="#cite_note-Jancin-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> It has been reported to have been successfully used to heal fracture nonunions.<span class="mw-ref" id="cite_ref-Giannotti_15-0"><a href="#cite_note-Giannotti-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Generally, due to HIPAA regulations, it is not publicized when American athletes receive this treatment to improve fracture recovery.<span class="mw-ref" id="cite_ref-Jancin_14-1"><a href="#cite_note-Jancin-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> But an Italian football player, Francesco Totti, was given teriparatide after a tibia/fibula fracture, and he unexpectedly recovered in time for the 2006 World Cup.<span class="mw-ref" id="cite_ref-Jancin_14-2"><a href="#cite_note-Jancin-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> It has been reported that Mark Mulder used it to recover from a hip fracture Oakland A's for the 2003 MLB playoffs<span class="mw-ref" id="cite_ref-Carroll_16-0"><a href="#cite_note-Carroll-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> and Terrell Owens to recover from an ankle fracture before the 2005 Super Bowl.<span class="mw-ref" id="cite_ref-Carroll_16-1"><a href="#cite_note-Carroll-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Administration">Administration</h3></summary>
    
<p>Teriparatide is administered by injection once a day in the thigh or abdomen.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Teriparatide should not be prescribed for people who are at increased risks for osteosarcoma. This includes those with Paget's Disease of bone or unexplained elevations of serum alkaline phosphate, open epiphysis, or prior radiation therapy involving the skeleton. In the animal studies and in one human case report, it was found to potentially be associated with developing osteosarcoma in test subjects after over 2 years of use. <span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>Patients should not start teriparatide until any <a href="Vitamin_D.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_D" title="Vitamin D">vitamin D</a> deficiency is corrected. <span class="mw-ref" id="cite_ref-Ref_a_18-0"><a href="#cite_note-Ref_a-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>Adverse effects of teriparatide include headache, nausea, dizziness, and limb pain.<span class="mw-ref" id="cite_ref-Rizzoli_9-2"><a href="#cite_note-Rizzoli-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span>
Teriparatide has a theoretical risk of osteosarcoma, which was found in rat studies but not confirmed in humans.<span class="mw-ref" id="cite_ref-Riek_2-1"><a href="#cite_note-Riek-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> This may be because unlike humans, rat bones grow for their entire life.<span class="mw-ref" id="cite_ref-Riek_2-2"><a href="#cite_note-Riek-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The tumors found in the rat studies were located on the end of the bones which grew after the injections began.<span class="mw-ref" id="cite_ref-Ref_a_18-1"><a href="#cite_note-Ref_a-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> After nine years on the market, there were only two cases of osteosarcoma reported.<span class="mw-ref" id="cite_ref-Kawai_10-1"><a href="#cite_note-Kawai-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> This risk was considered by the FDA as "extremely rare" (1 in 100,000 people)<span class="mw-ref" id="cite_ref-Rizzoli_9-3"><a href="#cite_note-Rizzoli-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> and is only slightly more than the incidence in the population over 60 years old (0.4 in 100,000).<span class="mw-ref" id="cite_ref-Rizzoli_9-4"><a href="#cite_note-Rizzoli-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>Teriparatide is a portion of human parathyroid hormone (PTH), amino acid sequence 1 through 34, of the complete molecule (containing 84 amino acids). Endogenous PTH is the primary regulator of calcium and phosphate metabolism in bone and kidney. PTH increases serum calcium, partially accomplishing this by increasing bone resorption.  Thus, chronically elevated PTH will deplete bone stores.  However, intermittent exposure to PTH will activate osteoblasts more than osteoclasts.  Thus, once-daily injections of teriparatide have a net effect of stimulating new bone formation leading to increased bone mineral density.<span class="mw-ref" id="cite_ref-Ref_b_19-0"><a href="#cite_note-Ref_b-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-Ref_c_20-0"><a href="#cite_note-Ref_c-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-Dempster_21-0"><a href="#cite_note-Dempster-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>Teriparatide is the first FDA approved agent for the treatment of osteoporosis that stimulates new bone formation.<span class="mw-ref" id="cite_ref-Ref_e_22-0"><a href="#cite_note-Ref_e-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="FDA_approval">FDA approval</h2></summary>
    
<p>Teriparatide was approved by the Food and Drug Administration (FDA) on 26 November 2002, for the treatment of osteoporosis in men and postmenopausal women who are at high risk for having a fracture. The drug is also approved to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture.  On October 4, 2019 the US FDA approved a recombinant teriparatide product, Teriparatide Injection (previously referred to as PF708 and Bonsity) from Pfenex Inc. Teriparatide Injection is the first FDA approved proposed therapeutic equivalent candidate to Forteo.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Combined_teriparatide_and_denosumab">Combined teriparatide and denosumab</h2></summary>
    
<p>Combined teriparatide and denosumab increased BMD more than either agent alone and more than has been reported with approved therapies. Combination treatment might, therefore, be useful to treat patients at high risk of fracture by increasing BMD. However, there is no evidence of fracture rate reduction in patients taking a teriparatide and denosumab combination. Moreover, the combination therapy group showed a significant decrease in their bone formation marker, indicating that denosumab, an antiresorptive agent, might actually counteract the effect of teriparatide, a bone formation anabolic agent, in bone formation. <span class="mw-ref" id="cite_ref-Ref_g_23-0"><a href="#cite_note-Ref_g-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Abaloparatide</li>
<li><span class="new">Osteolectin</span></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><a href="javascript:if(confirm('http://www.minsa.gob.pa/sites/default/files/alertas/nota_seguridad_teriparatida.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.minsa.gob.pa/sites/default/files/alertas/nota_seguridad_teriparatida.pdf'" tppabs="http://www.minsa.gob.pa/sites/default/files/alertas/nota_seguridad_teriparatida.pdf" class="external free external">http://www.minsa.gob.pa/sites/default/files/alertas/nota_seguridad_teriparatida.pdf</a></span></li><li id="cite_note-Riek-2"> <span id="mw-reference-text-cite_note-Riek-2" class="mw-reference-text"><cite class="citation journal cs1">Riek AE and Towler DA (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597219  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597219'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597219" class="external text external">"The pharmacological management of osteoporosis"</a>. <i>Missouri Medicine</i>. <b>108</b> (2): 118–23. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597219  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597219'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597219" class="external text external">3597219</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21568234  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21568234'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21568234" class="external text external">21568234</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: uses authors parameter (link)</span></span></li><li id="cite_note-pmid18003959-3"> <span id="mw-reference-text-cite_note-pmid18003959-3" class="mw-reference-text"><cite id="CITEREFSaagShaneBoonen2007" class="citation journal cs1">Saag KG, Shane E, Boonen S,  et al. (November 2007). "Teriparatide or alendronate in glucocorticoid-induced osteoporosis". <i>The New England Journal of Medicine</i>. <b>357</b> (20): 2028–39. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa071408  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa071408'" tppabs="https://doi.org/10.1056%2FNEJMoa071408" class="external text external">10.1056/NEJMoa071408</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18003959  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18003959'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18003959" class="external text external">18003959</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/EPAR/forsteo  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/EPAR/forsteo'" tppabs="https://www.ema.europa.eu/en/medicines/human/EPAR/forsteo" class="external text external">"Forsteo EPAR"</a>. <i>European Medicines Agency (EMA)</i>. 17 September 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">26 June</span> 2020</span>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFBfArM2017" class="citation web cs1">BfArM (2017-05-08). <a href="javascript:if(confirm('https://mri.cts-mrp.eu/Human/Downloads/DE_H_4292_001_PAR.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://mri.cts-mrp.eu/Human/Downloads/DE_H_4292_001_PAR.pdf'" tppabs="https://mri.cts-mrp.eu/Human/Downloads/DE_H_4292_001_PAR.pdf" class="external text external">"PUBLIC ASSESSMENT REPORT - Decentralised Procedure - Teriparatid-ratiopharm 20 µg / 80ml, Solution for injection"</a> <span class="cs1-format">(PDF)</span>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/EPAR/terrosa  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/EPAR/terrosa'" tppabs="https://www.ema.europa.eu/en/medicines/human/EPAR/terrosa" class="external text external">"Summary of the European public assessment report (EPAR) for Terrosa"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-08-14</span></span>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/summaries-opinion/qutavina  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/summaries-opinion/qutavina'" tppabs="https://www.ema.europa.eu/en/medicines/human/summaries-opinion/qutavina" class="external text external">"Qutavina: Pending EC decision"</a>. <i>European Medicines Agency (EMA)</i>. 25 June 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">26 June</span> 2020</span>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/summaries-opinion/livogiva  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/summaries-opinion/livogiva'" tppabs="https://www.ema.europa.eu/en/medicines/human/summaries-opinion/livogiva" class="external text external">"Livogiva: Pending EC decision"</a>. <i>European Medicines Agency (EMA)</i>. 25 June 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">26 June</span> 2020</span>.</cite></span></li><li id="cite_note-Rizzoli-9"> <span id="mw-reference-text-cite_note-Rizzoli-9" class="mw-reference-text"><cite id="CITEREFRizzoliReginsterBoonenBréart2011" class="citation journal cs1">Rizzoli, R.; Reginster, J. Y.; Boonen, S.; Bréart, G. R.; Diez-Perez, A.; Felsenberg, D.; Kaufman, J. M.; Kanis, J. A.; Cooper, C. (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135835'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135835" class="external text external">"Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis"</a>. <i>Calcified Tissue International</i>. <b>89</b> (2): 91–104. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00223-011-9499-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00223-011-9499-8'" tppabs="https://doi.org/10.1007%2Fs00223-011-9499-8" class="external text external">10.1007/s00223-011-9499-8</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135835'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135835" class="external text external">3135835</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21637997  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21637997'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21637997" class="external text external">21637997</a>.</cite></span></li><li id="cite_note-Kawai-10"> <span id="mw-reference-text-cite_note-Kawai-10" class="mw-reference-text"><cite id="CITEREFKawaiMödderKhoslaRosen2011" class="citation journal cs1">Kawai, M.; Mödder, U. I.; Khosla, S.; Rosen, C. J. (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135105  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135105'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135105" class="external text external">"Emerging therapeutic opportunities for skeletal restoration"</a>. <i>Nature Reviews Drug Discovery</i>. <b>10</b> (2): 141–156. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrd3299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrd3299'" tppabs="https://doi.org/10.1038%2Fnrd3299" class="external text external">10.1038/nrd3299</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135105  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135105'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135105" class="external text external">3135105</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21283108  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21283108'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21283108" class="external text external">21283108</a>.</cite></span></li><li id="cite_note-Murad-11"> <span id="mw-reference-text-cite_note-Murad-11" class="mw-reference-text"><cite id="CITEREFMuradDrakeMullanMauck2012" class="citation journal cs1">Murad, M. H.; Drake, M. T.; Mullan, R. J.; Mauck, K. F.; Stuart, L. M.; Lane, M. A.; Abu Elnour, N. O.; Erwin, P. J.; Hazem, A.; Puhan, M. A.; Li, T.; Montori, V. M. (2012). <a href="javascript:if(confirm('https://doi.org/10.1210/jc.2011-3060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210/jc.2011-3060'" tppabs="https://doi.org/10.1210/jc.2011-3060" class="external text external">"Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis"</a>. <i>Journal of Clinical Endocrinology &amp; Metabolism</i>. <b>97</b> (6): 1871–1880. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1210%2Fjc.2011-3060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjc.2011-3060'" tppabs="https://doi.org/10.1210%2Fjc.2011-3060" class="external text external">10.1210/jc.2011-3060</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22466336  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22466336'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22466336" class="external text external">22466336</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text">O'Connor KM. Evaluation and Treatment of Osteoporosis. Med Clin N Am. 2016; 100:807-26</span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFDíez-PérezMarinEriksenKendler2019" class="citation journal cs1">Díez-Pérez A, Marin F, Eriksen EF, Kendler DL, Krege JH, Delgado-Rodríguez M (2019). <a href="javascript:if(confirm('https://doi.org/10.1016/j.bone.2018.09.020  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.bone.2018.09.020'" tppabs="https://doi.org/10.1016/j.bone.2018.09.020" class="external text external">"Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis"</a>. <i>Bone</i>. <b>120</b>: 1–8. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bone.2018.09.020  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bone.2018.09.020'" tppabs="https://doi.org/10.1016%2Fj.bone.2018.09.020" class="external text external">10.1016/j.bone.2018.09.020</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30268814  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30268814'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30268814" class="external text external">30268814</a>.</cite></span></li><li id="cite_note-Jancin-14"> <span id="mw-reference-text-cite_note-Jancin-14" class="mw-reference-text"><cite id="CITEREFBruce_Jancin2011" class="citation news cs1">Bruce Jancin (2011-12-12). <a href="javascript:if(confirm('http://www.internalmedicinenews.com/index.php?id=2049&type=98&tx_ttnews%5btt_news%5d=93933&cHash=da03e20e36  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.internalmedicinenews.com/index.php?id=2049&type=98&tx_ttnews%5btt_news%5d=93933&cHash=da03e20e36'" tppabs="http://www.internalmedicinenews.com/index.php?id=2049&type=98&tx_ttnews%5btt_news%5d=93933&cHash=da03e20e36" class="external text external">"Accelerating Fracture Healing With Teriparatide"</a>. Internal Medicine News Digital Network<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-09-20</span></span>.</cite></span></li><li id="cite_note-Giannotti-15"> <span id="mw-reference-text-cite_note-Giannotti-15" class="mw-reference-text"><cite id="CITEREFGiannottiBottaiDell’OssoPini2013" class="citation journal cs1">Giannotti, S.; Bottai, V.; Dell’Osso, G.; Pini, E.; De Paola, G.; Bugelli, G.; Guido, G. (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796998  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796998'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796998" class="external text external">"Current medical treatment strategies concerning fracture healing"</a>. <i>Clinical Cases in Mineral and Bone Metabolism</i>. <b>10</b> (2): 116–120. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796998  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796998'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796998" class="external text external">3796998</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24133528  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24133528'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24133528" class="external text external">24133528</a>.</cite></span></li><li id="cite_note-Carroll-16"> <span id="mw-reference-text-cite_note-Carroll-16" class="mw-reference-text"><cite id="CITEREFWilliam_L._Carroll2005" class="citation book cs1">William L. Carroll (2005). <a href="javascript:if(confirm('http://www.worldcat.org/wcpa/servlet/DCARead?standardNo=156663668X&standardNoType=1&excerpt=true  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.worldcat.org/wcpa/servlet/DCARead?standardNo=156663668X&standardNoType=1&excerpt=true'" tppabs="http://www.worldcat.org/wcpa/servlet/DCARead?standardNo=156663668X&standardNoType=1&excerpt=true" class="external text external">"Chapter 1: Defining the Issue"</a>. <i>The Juice: The Real Story of Baseball's Drug Problems</i>. ISBN<span>&nbsp;</span><bdi>1-56663-668-X</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">2013-09-23</span></span>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text">Harper KD, Krege JH, Marcus R, et al. Osteosarcoma and teriparatide? J Bone Miner Res 2007;22(2):334</span></li><li id="cite_note-Ref_a-18"> <span id="mw-reference-text-cite_note-Ref_a-18" class="mw-reference-text"><a href="javascript:if(confirm('https://www.drugs.com/pro/forteo.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pro/forteo.html'" tppabs="https://www.drugs.com/pro/forteo.html" class="external free external">https://www.drugs.com/pro/forteo.html</a></span></li><li id="cite_note-Ref_b-19"> <span id="mw-reference-text-cite_note-Ref_b-19" class="mw-reference-text"><cite id="CITEREFBauerAubAlbright1929" class="citation journal cs1">Bauer, E; Aub, JC; Albright, F (1929). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131520'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131520" class="external text external">"Studies of calcium and phosphorus metabolism: V. Study of the bone trabeculae as a readily available reserve supply of calcium"</a>. <i>J Exp Med</i>. <b>49</b> (1): 145–162. doi:<a href="javascript:if(confirm('https://doi.org/10.1084%2Fjem.49.1.145  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1084%2Fjem.49.1.145'" tppabs="https://doi.org/10.1084%2Fjem.49.1.145" class="external text external">10.1084/jem.49.1.145</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131520'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131520" class="external text external">2131520</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19869533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19869533'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19869533" class="external text external">19869533</a>.</cite></span></li><li id="cite_note-Ref_c-20"> <span id="mw-reference-text-cite_note-Ref_c-20" class="mw-reference-text"><cite id="CITEREFSelye1932" class="citation journal cs1">Selye, H (1932). "On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol". <i>Endocrinology</i>. <b>16</b> (5): 547–558. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fendo-16-5-547  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fendo-16-5-547'" tppabs="https://doi.org/10.1210%2Fendo-16-5-547" class="external text external">10.1210/endo-16-5-547</a>.</cite></span></li><li id="cite_note-Dempster-21"> <span id="mw-reference-text-cite_note-Dempster-21" class="mw-reference-text"><cite id="CITEREFDempsterCosmanParisienShen1993" class="citation journal cs1">Dempster, D. W.; Cosman, F.; Parisien, M.; Shen, V.; Lindsay, R. (1993). "Anabolic actions of parathyroid hormone on bone". <i>Endocrine Reviews</i>. <b>14</b> (6): 690–709. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fedrv-14-6-690  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fedrv-14-6-690'" tppabs="https://doi.org/10.1210%2Fedrv-14-6-690" class="external text external">10.1210/edrv-14-6-690</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8119233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8119233'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8119233" class="external text external">8119233</a>.</cite></span></li><li id="cite_note-Ref_e-22"> <span id="mw-reference-text-cite_note-Ref_e-22" class="mw-reference-text"><a href="javascript:if(confirm('http://www.forteo.com/secure/user/index.jsp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.forteo.com/secure/user/index.jsp'" tppabs="http://www.forteo.com/secure/user/index.jsp" class="external text external">Fortéo: teriparatide (rDNA origin) injection</a> <a href="javascript:if(confirm('https://web.archive.org/web/20091227173148/http://www.forteo.com/secure/user/index.jsp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20091227173148/http://www.forteo.com/secure/user/index.jsp'" tppabs="https://web.archive.org/web/20091227173148/http://www.forteo.com/secure/user/index.jsp" class="external text external">Archived</a><span> 2009-12-27 at the </span>Wayback Machine</span></li><li id="cite_note-Ref_g-23"> <span id="mw-reference-text-cite_note-Ref_g-23" class="mw-reference-text"><cite id="CITEREFTsaiUihleinLeeKumbhani2013" class="citation journal cs1">Tsai, Joy N; Uihlein, Alexander V; Lee, Hang; Kumbhani, Ruchit; Siwila-Sackman, Erica; McKay, Elizabeth A; Burnett-Bowie, Sherri-Ann M; Neer, Robert M; Leder, Benjamin Z (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010689  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010689'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010689" class="external text external">"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: The DATA study randomised trial"</a>. <i>The Lancet</i>. <b>382</b> (9886): 1694–1700. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2813%2960856-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2813%2960856-9'" tppabs="https://doi.org/10.1016%2FS0140-6736%2813%2960856-9" class="external text external">10.1016/S0140-6736(13)60856-9</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010689  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010689'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010689" class="external text external">4010689</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24517156  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24517156'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24517156" class="external text external">24517156</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a603018.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a603018.html'" tppabs="https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a603018.html" class="external text external">Teriparatide at National Institutes of Health</a>.</li>
<li><a href="javascript:if(confirm('http://www.medscape.com/viewarticle/464171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/464171'" tppabs="http://www.medscape.com/viewarticle/464171" class="external text external">When to Use Teriparatide - Medscape</a>.</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Calcium_homeostasis_(H05)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Calcium_homeostasis_(H05)" style="font-size:114%;margin:0 4em"><a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">Calcium</a> homeostasis (H05)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Parathyroid hormone analogues</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Teriparatide.htm" tppabs="https://ptable.com/wiki/compounds/A/Teriparatide" title="Teriparatide">Teriparatide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-parathyroid hormone agents</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Calcitonin derivatives</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Calcitonin</li>
<li>Elcatonin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Calcimimetics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cinacalcet.htm" tppabs="https://ptable.com/wiki/compounds/A/Cinacalcet" title="Cinacalcet">Cinacalcet</a></li>
<li>Etelcalcetide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Vitamin D analogues</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Doxercalciferol</li>
<li><a href="Paricalcitol.htm" tppabs="https://ptable.com/wiki/compounds/A/Paricalcitol" title="Paricalcitol">Paricalcitol</a></li>
<li><a href="Cholecalciferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholecalciferol" title="Cholecalciferol">Cholecalciferol</a></li>
<li><a href="Ergocalciferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergocalciferol" title="Ergocalciferol">Ergocalciferol</a></li>
<li><a href="Calcitriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcitriol" title="Calcitriol">Calcitriol</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<span>
</span><div role="navigation" class="navbox" aria-labelledby="Signaling_peptide/protein_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Signaling_peptide/protein_receptor_modulators" style="font-size:114%;margin:0 4em">Signaling peptide/protein receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Adiponectin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">AdipoR<sub>1</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptide:</i> Adiponectin</li>
<li><span class="new">ADP-355</span></li>
<li><span class="new">ADP-399</span>; <i>Non-peptide:</i> AdipoRon</li>
<li>(–)-Arctigenin</li>
<li>Arctiin</li>
<li><a href="Gramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Gramine" title="Gramine">Gramine</a></li>
<li><a href="Matairesinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Matairesinol" title="Matairesinol">Matairesinol</a></li></ul>

<ul><li><i>Antagonists:</i> <i>Peptide:</i> <span class="new">ADP-400</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">AdipoR<sub>2</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptide:</i> Adiponectin</li>
<li><span class="new">ADP-355</span></li>
<li><span class="new">ADP-399</span>; <i>Non-peptide:</i> AdipoRon</li>
<li>Deoxyschizandrin</li>
<li><a href="Parthenolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Parthenolide" title="Parthenolide">Parthenolide</a></li>
<li><span class="new">Syringing</span></li>
<li>Taxifoliol</li></ul>

<ul><li><i>Antagonists:</i> <i>Peptide:</i> <span class="new">ADP-400</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Angiotensin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Bradykinin</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <a href="Bradykinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bradykinin" title="Bradykinin">Bradykinin</a></li>
<li>Kallidin</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">FR-173657</span></li>
<li><a href="Icatibant.htm" tppabs="https://ptable.com/wiki/compounds/A/Icatibant" title="Icatibant">Icatibant</a></li>
<li>LF22-0542</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CGRP</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Amylin</li>
<li>CGRP</li>
<li><a href="Pramlintide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pramlintide" title="Pramlintide">Pramlintide</a></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Atogepant</span></li>
<li><span class="new">BI 44370 TA</span></li>
<li><span class="new">CGRP (8-37)</span></li>
<li><span class="new">MK-3207</span></li>
<li>Olcegepant</li>
<li>Rimegepant</li>
<li><span class="new">SB-268262</span></li>
<li><a href="Telcagepant.htm" tppabs="https://ptable.com/wiki/compounds/A/Telcagepant" title="Telcagepant">Telcagepant</a></li>
<li>Ubrogepant</li></ul>

<ul><li><i>Antibodies:</i> Eptinezumab</li>
<li>Erenumab</li>
<li>Fremanezumab</li>
<li>Galcanezumab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cholecystokinin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCK<sub>A</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Cholecystokinin</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Amiglumide</span></li>
<li>Asperlicin</li>
<li>Devazepide</li>
<li>Dexloxiglumide</li>
<li><span class="new">Lintitript</span></li>
<li>Lorglumide</li>
<li><span class="new">Loxiglumide</span></li>
<li><span class="new">Pranazepide</span></li>
<li>Proglumide</li>
<li><span class="new">Tarazepide</span></li>
<li><span class="new">Tomoglumide</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCK<sub>B</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Cholecystokinin</li>
<li>CCK-4</li>
<li>Gastrin</li>
<li><a href="Pentagastrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentagastrin" title="Pentagastrin">Pentagastrin (CCK-5)</a></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Ceclazepide</span></li>
<li>CI-988 (PD-134308)</li>
<li><span class="new">Itriglumide</span></li>
<li><span class="new">L-365,360</span></li>
<li><span class="new">Netazepide</span></li>
<li>Proglumide</li>
<li><span class="new">Spiroglumide</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> <span class="new">Nastorazepide</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CRH</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CRF<sub>1</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Cortagine</span></li>
<li>Corticorelin</li>
<li>Corticotropin-releasing hormone</li>
<li>Sauvagine</li>
<li><span class="new">Stressin I</span></li>
<li>Urocortin</li></ul>

<ul><li><i>Antagonists:</i> Antalarmin</li>
<li>Astressin-B</li>
<li>CP-154,526</li>
<li>Emicerfont</li>
<li>Hypericin</li>
<li><span class="new">LWH-234</span></li>
<li><span class="new">NBI-27914</span></li>
<li><span class="new">NBI-74788</span></li>
<li>Pexacerfont</li>
<li><span class="new">R-121919</span></li>
<li><span class="new">TS-041</span></li>
<li>Verucerfont</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CRF<sub>2</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Corticorelin</li>
<li>Corticotropin-releasing hormone</li>
<li>Sauvagine</li>
<li>Urocortin</li></ul>

<ul><li><i>Antagonists:</i> Astressin-B</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cytokine</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">See here instead.</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Endothelin</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Endothelin 1</li>
<li>Endothelin 2</li>
<li>Endothelin 3</li>
<li><span class="new">IRL-1620</span></li>
<li>Sarafotoxin</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">A-192621</span></li>
<li><span class="new">ACT-132577</span></li>
<li>Ambrisentan</li>
<li><span class="new">Aprocitentan</span></li>
<li>Atrasentan</li>
<li><span class="new">Avosentan</span></li>
<li><a href="Bosentan.htm" tppabs="https://ptable.com/wiki/compounds/A/Bosentan" title="Bosentan">Bosentan</a></li>
<li>BQ-123</li>
<li>BQ-788</li>
<li><span class="new">Clazosentan</span></li>
<li>Darusentan</li>
<li><span class="new">Edonentan</span></li>
<li><span class="new">Enrasentan</span></li>
<li><span class="new">Fandosentan</span></li>
<li><span class="new">Feloprentan</span></li>
<li>Macitentan</li>
<li><span class="new">Nebentan</span></li>
<li>Sitaxentan</li>
<li><span class="new">Sparsentan</span></li>
<li>Tezosentan</li>
<li>Zibotentan</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Galanin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GAL<sub>1</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Galanin</li>
<li><span class="new">Galanin (1-15)</span></li>
<li>Galanin-like peptide</li>
<li>Galmic</li>
<li>Galnon</li>
<li><span class="new">NAX 810-2</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">C7</span></li>
<li><span class="new">Dithiepine-1,1,4,4-tetroxide</span></li>
<li><span class="new">Galantide (M15)</span></li>
<li><span class="new">M32</span></li>
<li><span class="new">M35</span></li>
<li><span class="new">M40</span></li>
<li><span class="new">SCH-202596</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GAL<sub>2</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Galanin</li>
<li><span class="new">Galanin (1-15)</span></li>
<li><span class="new">Galanin (2-11)</span></li>
<li>Galanin-like peptide</li>
<li>Galmic</li>
<li>Galnon</li>
<li><span class="new">J18</span></li>
<li><span class="new">NAX 810-2</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">C7</span></li>
<li><span class="new">Galantide (M15)</span></li>
<li><span class="new">M32</span></li>
<li><span class="new">M35</span></li>
<li><span class="new">M40</span></li>
<li><span class="new">M871</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GAL<sub>3</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Galanin</li>
<li><span class="new">Galanin (1-15)</span></li>
<li>Galmic</li>
<li>Galnon</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">C7</span></li>
<li><span class="new">Galantide (M15)</span></li>
<li><span class="new">GalR3ant</span></li>
<li>HT-2157</li>
<li><span class="new">M32</span></li>
<li><span class="new">M35</span></li>
<li><span class="new">M40</span></li>
<li>SNAP-37889</li>
<li><span class="new">SNAP-398299</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Ghrelin/GHS</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GH</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GHRH</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GLP</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GLP-1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Albiglutide</li>
<li><span class="new">Beinaglutide</span></li>
<li>Dulaglutide</li>
<li><span class="new">Efpeglenatide</span></li>
<li><a href="Exenatide.htm" tppabs="https://ptable.com/wiki/compounds/A/Exenatide" title="Exenatide">Exenatide</a></li>
<li>GLP-1</li>
<li><span class="new">Langlenatide</span></li>
<li>Liraglutide</li>
<li>Lixisenatide</li>
<li>Oxyntomodulin</li>
<li><span class="new">Pegapamodutide</span></li>
<li>Semaglutide</li>
<li>Taspoglutide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GLP-2</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Apraglutide</span></li>
<li><span class="new">Elsiglutide</span></li>
<li><span class="new">Glepaglutide</span></li>
<li>GLP-2</li>
<li>Teduglutide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Propeptides:</i> Preproglucagon</li>
<li>Proglucagon</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Glucagon</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Dasiglucagon</span></li>
<li><a href="Glucagon.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucagon" title="Glucagon">Glucagon</a></li>
<li>Oxyntomodulin</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Adomeglivant</span></li>
<li><span class="new">L-168,049</span></li>
<li><span class="new">LGD-6972</span></li></ul>

<ul><li><i>Propeptides:</i> Preproglucagon</li>
<li>Proglucagon</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">GnRH</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Gonadotropin</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Growth factor</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">See here instead.</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Insulin</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Chaetochromin (4548-G05)</li>
<li>Insulin-like growth factor 1</li>
<li>Insulin-like growth factor 2</li>
<li><a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">Insulin</a></li>
<li>Insulin aspart</li>
<li>Insulin degludec</li>
<li>Insulin detemir</li>
<li>Insulin glargine</li>
<li>Insulin glulisine</li>
<li>Insulin lispro</li>
<li><a href="Mecasermin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mecasermin" title="Mecasermin">Mecasermin</a></li>
<li>Mecasermin rinfabate</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">BMS-754807</span></li>
<li><span class="new">S661</span></li>
<li><span class="new">S961</span></li></ul>

<ul><li><i>Kinase inhibitors:</i> Linsitinib</li></ul>

<ul><li><i>Antibodies:</i> <span class="new">Xentuzumab</span> (against IGF-1 and IGF-2)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Kisspeptin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Kisspeptin</li>
<li><span class="new">Kisspeptin-10</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Kisspeptin-234</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Leptin</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Leptin</li>
<li>Metreleptin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">MCH</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">MCH<sub>1</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Melanin-concentrating hormone</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">ATC-0065</span></li>
<li>ATC-0175</li>
<li>GW-803430</li>
<li>NGD-4715</li>
<li>SNAP-7941</li>
<li>SNAP-94847</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">MCH<sub>2</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Melanin-concentrating hormone</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Melanocortin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Neuropeptide FF</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Neuropeptide AF</span></li>
<li>Neuropeptide FF</li>
<li><span class="new">Neuropeptide SF (RFRP-1)</span></li>
<li><span class="new">Neuropeptide VF (RFRP-3)</span></li></ul>

<ul><li><i>Antagonists:</i> BIBP-3226</li>
<li><span class="new">RF9</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Neuropeptide S</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Neuropeptide S</li></ul>

<ul><li><i>Antagonists:</i> ML-154</li>
<li>SHA-68</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Neuropeptide_Y_receptor.htm" tppabs="https://ptable.com/wiki/compounds/A/Neuropeptide_Y_receptor" title="Neuropeptide Y receptor">Neuropeptide Y</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Y<sub>1</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Neuropeptide Y</li>
<li>Peptide YY</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">BIBO-3304</span></li>
<li>BIBP-3226</li>
<li><span class="new">BVD-10</span></li>
<li><span class="new">GR-231118</span></li>
<li><span class="new">PD-160170</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Y<sub>2</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">2-Thiouridine 5'-triphosphate</span></li>
<li>Neuropeptide Y</li>
<li><span class="new">Neuropeptide Y (13-36)</span></li>
<li>Peptide YY</li>
<li><span class="new">Peptide YY (3-36)</span></li></ul>

<ul><li><i>Antagonists:</i> BIIE-0246</li>
<li><span class="new">JNJ-5207787</span></li>
<li><span class="new">SF-11</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Y<sub>4</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">GR-231118</span></li>
<li>Neuropeptide Y</li>
<li>Pancreatic polypeptide</li>
<li>Peptide YY</li></ul>

<ul><li><i>Antagonists:</i> UR-AK49</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Y<sub>5</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">BWX-46</span></li>
<li>Neuropeptide Y</li>
<li>Peptide YY</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">CGP-71683</span></li>
<li><span class="new">FMS-586</span></li>
<li><span class="new">L-152,804</span></li>
<li>Lu AA-33810</li>
<li><span class="new">MK-0557</span></li>
<li><span class="new">NTNCB</span></li>
<li>Velneperit (S-2367)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Neurotensin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">NTS<sub>1</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Neurotensin</li>
<li>Neuromedin N</li></ul>

<ul><li><i>Antagonists:</i> Meclinertant</li>
<li>SR-142948</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">NTS<sub>2</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Neurotensin</li></ul>

<ul><li><i>Antagonists:</i> <a href="Levocabastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levocabastine" title="Levocabastine">Levocabastine</a></li>
<li>SR-142948</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Opioid</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">See here instead.</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Orexin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">OX<sub>1</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Orexin (A, B)</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">ACT-335827</span></li>
<li><span class="new">ACT-462206</span></li>
<li>Almorexant</li>
<li>Filorexant</li>
<li>Lemborexant</li>
<li>Nemorexant</li>
<li><span class="new">RTIOX-276</span></li>
<li>SB-334867</li>
<li>SB-408124</li>
<li>SB-649868</li>
<li>Suvorexant</li>
<li><span class="new">TCS-1102</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">OX<sub>2</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Orexin (A, B)</li>
<li><span class="new">SB-668875</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">ACT-335827</span></li>
<li><span class="new">ACT-462206</span></li>
<li>Almorexant</li>
<li>EMPA</li>
<li>Filorexant</li>
<li><span class="new">JNJ-10397049</span></li>
<li>Lemborexant</li>
<li><span class="new">MK-1064</span></li>
<li>SB-649868</li>
<li>Seltorexant</li>
<li>Suvorexant</li>
<li><span class="new">TCS-1102</span></li>
<li>TCS-OX2-29</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Oxytocin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Prolactin</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Growth_hormone" title="Growth hormone">Growth hormone</a></li>
<li>Human placental lactogen</li>
<li>Placental growth hormone (growth hormone variant)</li>
<li>Prolactin</li>
<li><span class="new">S179D-hPRL</span></li>
<li><a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Somatotropin" title="Somatotropin" class="mw-redirect">Somatotropin</a></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Δ1–9-G129R-hPRL</span></li>
<li><span class="new">Δ1–14-G129R-hPRL</span></li>
<li><span class="new">G120K-hGH</span></li>
<li><span class="new">G129R-hPRL</span></li></ul>

<ul><li><i>Prolactin modulators:</i> <i>Prolactin inhibitors:</i> D<sub>2</sub> receptor agonists (e.g., <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">cabergoline</a>); <i>Prolactin releasers:</i> D<sub>2</sub> receptor antagonists (e.g., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>)</li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>)</li>
<li>Progestogens (e.g., <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">PTH</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Abaloparatide</li>
<li>Parathyroid hormone</li>
<li>Parathyroid hormone-related protein (PTHrP)</li>
<li><span class="new">Semparatide</span></li>
<li><a href="Teriparatide.htm" tppabs="https://ptable.com/wiki/compounds/A/Teriparatide" title="Teriparatide">Teriparatide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Relaxin</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Insulin-like factor 3</li>
<li>Relaxin (<span class="new">1</span>, <span class="new">2</span>, 3)</li>
<li>Serelaxin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Somatostatin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Tachykinin</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">TRH</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Azetirelin</span></li>
<li>Fertirelin</li>
<li><span class="new">Montirelin</span></li>
<li><span class="new">Orotirelin</span></li>
<li><span class="new">Posatirelin</span></li>
<li><a href="Thyrotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Protirelin" title="Protirelin" class="mw-redirect">Protirelin</a></li>
<li><span class="new">Rovatirelin</span></li>
<li>Taltirelin</li>
<li><a href="Thyrotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Thyrotropin-releasing_hormone" title="Thyrotropin-releasing hormone">TRH (TRF)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">TSH</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Thyrotropin alfa</li>
<li><a href="Thyroid-stimulating_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Thyroid-stimulating_hormone" title="Thyroid-stimulating hormone">TSH (thyrotropin)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Vasopressin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">VIP/PACAP</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">VIPR<sub>1</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptide:</i> <span class="new">Bay 55-9837</span></li>
<li><span class="new">LBT-3393</span></li>
<li>PACAP</li>
<li>VIP</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">VIPR<sub>2</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptide:</i> LBT-3627</li>
<li>PACAP</li>
<li>VIP</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">PAC<sub>1</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> PACAP</li>
<li><span class="new">PACAP (1-27)</span></li>
<li><span class="new">PACAP (1-38)</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">PACAP (6-38)</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">PHI</span></li>
<li><span class="new">PHM</span></li>
<li><span class="new">PHV</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Endogenous:</i> Adrenomedullin</li>
<li>Apelin</li>
<li>Asprosin</li>
<li>Bombesin</li>
<li>Calcitonin</li>
<li><a href="Carnosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carnosine" title="Carnosine">Carnosine</a></li>
<li>CART</li>
<li>CLIP</li>
<li>DSIP</li>
<li>Enteroglucagon</li>
<li>Formyl peptide</li>
<li>GALP</li>
<li>GIP</li>
<li>GRP</li>
<li>Integrin ligands (collagens, fibrinogen, fibronectin, laminins, ICAM-1, ICAM-2, osteopontin, VCAM-1, vitronectin)</li>
<li>Kininogens</li>
<li>Motilin</li>
<li>Natriuretic peptides (ANP, BNP, CNP, urodilatin)</li>
<li>Nesfatin-1</li>
<li>Neuromedin B</li>
<li>Neuromedin N</li>
<li>Neuromedin S</li>
<li>Neuromedin U</li>
<li>Obestatin</li>
<li>Osteocalcin</li>
<li>Resistin</li>
<li><a href="Secretin.htm" tppabs="https://ptable.com/wiki/compounds/A/Secretin" title="Secretin">Secretin</a></li>
<li>Thymopoietin</li>
<li>Thymosins</li>
<li>Thymulin</li>
<li>Urotensin-II</li>
<li>VGF</li></ul>

<ul><li><i>Exogenous:</i> Lifitegrast (LFA-1 antagonist)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd></dl>
</div></td></tr></tbody></table></div><span>
</span>



<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-06-27" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Teriparatide&oldid=964694648  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Teriparatide&oldid=964694648'" tppabs="https://en.wikipedia.org/wiki/?title=Teriparatide&oldid=964694648">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>